Directory
>
Eren Demirhan
Eren Demirhan
Vice President, Head of Biometrics | Nurix Therapeutics
San Francisco, California, United States
Eren Demirhan
Summary
Eren Demirhan is a seasoned professional in the life sciences sector, currently serving as Vice President and Head of Biometrics at Nurix Therapeutics. With a robust background in biostatistics and clinical development, he has significantly influenced drug discovery and development pipelines across various therapeutic areas. Eren's leadership experience is underscored by his role in optimizing drug development processes and providing statistical expertise to cross-functional teams. He holds a Ph.D. in Statistics and an MBA from Kenan-Flagler Business School, blending technical acumen with strategic business insights. His career highlights include pioneering innovative study designs for global biosimilar clinical programs and overseeing new drug application registrations in oncology and multiple sclerosis. Eren is passionate about leveraging data analytics to enhance patient outcomes and drive industry advancements.
Eren Demirhan
Work Experience
Vice President, Head of Biometrics at
Nurix Therapeutics
March 2021 - Present
Director of Biostatistics at
Allogene Therapeutics
January 2018 - January 2021
Manager at
ZS
January 2018 - January 2019
Director Biostatistics at
Pfizer, Inc.
January 2015 - January 2018
Sr. Manager, Biostatistics at
Amgen, Inc.
January 2014 - January 2015
Sr. Biostatistician at
Biogen
January 2012 - January 2014
Sr. Principal Biostatistician at
Novartis
January 2008 - January 2012
Statistical Scientist at
GSK
January 2006 - January 2008
Eren Demirhan
Education
University of North Carolina at Chapel Hill - Kenan-Flagler Business School, Master Of Business Administration (M.B.A.)
January 2013 - January 2015
North Carolina State University, Doctor Of Philosophy (Ph.D.)
January 2003 - January 2008
Middle East Tecnical University, Bachelor Of Science
January 1998 - January 2002
Frequently Asked Questions about Eren Demirhan
What is Eren Demirhan email address?
Eren Demirhan's primary email address is *********@nurixtx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Eren Demirhan work for?
Eren Demirhan is a Vice President, Head of Biometrics at Nurix Therapeutics, a company specializing in Commercial physical research.
Where Eren Demirhan graduated from?
Eren Demirhan holds a degree in Strategy & Consulting from University of North Carolina at Chapel Hill - Kenan-Flagler Business School.
How can I directly contact Eren Demirhan?
To contact Eren Demirhan directly, you can use the email address *********@nurixtx.com. Complete contact information is available upon registration with Muraena.
Who is Eren Demirhan?
Eren Demirhan is a seasoned professional in the life sciences sector, currently serving as Vice President and Head of Biometrics at Nurix Therapeutics. With a robust background in biostatistics and clinical development, he has significantly influenced drug discovery and development pipelines across various therapeutic areas. Eren's leadership experience is underscored by his role in optimizing drug development processes and providing statistical expertise to cross-functional teams. He holds a Ph.D. in Statistics and an MBA from Kenan-Flagler Business School, blending technical acumen with strategic business insights. His career highlights include pioneering innovative study designs for global biosimilar clinical programs and overseeing new drug application registrations in oncology and multiple sclerosis. Eren is passionate about leveraging data analytics to enhance patient outcomes and drive industry advancements.
Eren`s contact details
*********@nurixtx.com
*************@allogene.com
Colleagues
Chief Medical Officer
Sr Vice President
Executive Director, Preclinical Pharmacology
Vice President and Head of Clinical Operations
Chief People Officer
Board Member, Chair of Audit Committee and Chair of Nomination and Governance Committee
Vice President and Head of Clinical Science
Executive Director, ADME & Analytical Chem
VP, Alliance & Research Project Management